Taiwan FDA registration 2dd894554a8fcfae3632154c51df1a9b
Dairo Express Pregnancy Test Series
TW: 戴洛快速驗孕系列
Taiwan·Risk Class 2·GUANGZHOU WONDFO BIOTECH CO., LTD.·Registered Jul 06, 2020 – Jul 06, 2025ExpiredRegistration details
- Analysis ID
- 2dd894554a8fcfae3632154c51df1a9b
- Customs Code
- DHA09200099800
Company information
- Manufacturer
- GUANGZHOU WONDFO BIOTECH CO., LTD.
- Manufacturer Country
- China
- Authorized Representative
- SUNGYIN BIO INTERNATIONAL CO., LTD.
Product details
- Intended Use
- It is used to qualitatively detect human chorionic gonadotropin (HCG) in women's urine to provide a basis for early pregnancy diagnosis.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Input;; Chinese goods
Dates and status
- Registration Date
- Jul 06, 2020
- Expiry Date
- Jul 06, 2025
About this record
Access comprehensive regulatory information for Dairo Express Pregnancy Test Series in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2dd894554a8fcfae3632154c51df1a9b and manufactured by GUANGZHOU WONDFO BIOTECH CO., LTD.. The authorized representative in Taiwan is SUNGYIN BIO INTERNATIONAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices